UKHSA reports nearly three-quarters of women who gave birth in September were vaccinated against whooping cough during pregnancy, providing vital early protection to newborn babies.
Nearly three-quarters of women who gave birth in September were vaccinated, helping to give their babies vital early protection against whooping cough (pertussis). This strong uptake demonstrates the success of the maternal pertussis vaccination program.
Maternal pertussis vaccination program:
Why vaccinate in pregnancy:
Whooping cough risks for infants:
73% coverage significance: While this represents good uptake, there remains room for improvement to reach the 75% national target and protect more babies. Every vaccinated mother means another infant protected during their most vulnerable weeks.
Barriers addressed:
Public health impact: Since the maternal pertussis program began in 2012, there has been a dramatic reduction in infant whooping cough cases and deaths. The program is a key pillar of infant protection strategy, complementing the routine childhood immunization schedule.
UKHSA encourages all pregnant women to accept the whooping cough vaccine when offered during antenatal care to give their babies the best protection from birth.
Pertussis (whooping cough), Bordetella pertussis
萃取時間: 2026-02-05T22:58:00Z 資料來源: UK Health Security Agency